Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
J Biol Chem. 2011 Jul 8;286(27):24170-9. doi: 10.1074/jbc.M110.212274. Epub 2011 May 18.
Platelets contain high levels of Src family kinases (SFKs), but their functional role downstream of G protein pathways has not been completely understood. We found that platelet shape change induced by selective G(12/13) stimulation was potentiated by SFK inhibitors, which was abolished by intracellular calcium chelation. Platelet aggregation, secretion, and intracellular Ca(2+) mobilization mediated by low concentrations of SFLLRN or YFLLRNP were potentiated by SFK inhibitors. However, 2-methylthio-ADP-induced intracellular Ca(2+) mobilization and platelet aggregation were not affected by PP2, suggesting the contribution of SFKs downstream of G(12/13), but not G(q)/G(i), as a negative regulator to platelet activation. Moreover, PP2 potentiated YFLLRNP- and AYPGKF-induced PKC activation, indicating that SFKs downstream of G(12/13) regulate platelet responses through the negative regulation of PKC activation as well as calcium response. SFK inhibitors failed to potentiate platelet responses in the presence of G(q)-selective inhibitor YM254890 or in G(q)-deficient platelets, indicating that SFKs negatively regulate platelet responses through modulation of G(q) pathways. Importantly, AYPGKF-induced platelet aggregation and PKC activation were potentiated in Fyn-deficient but not in Lyn-deficient mice compared with wild-type littermates. We conclude that SFKs, especially Fyn, activated downstream of G(12/13) negatively regulate platelet responses by inhibiting intracellular calcium mobilization and PKC activation through G(q) pathways.
血小板中含有高水平的Src 家族激酶(SFKs),但其在 G 蛋白途径下游的功能作用尚未完全理解。我们发现,选择性 G(12/13)刺激诱导的血小板形态变化被 SFK 抑制剂增强,而细胞内钙螯合则消除了这种增强作用。低浓度 SFLLRN 或 YFLLRNP 介导的血小板聚集、分泌和细胞内 Ca(2+)动员被 SFK 抑制剂增强。然而,2-甲基硫代-ADP 诱导的细胞内 Ca(2+)动员和血小板聚集不受 PP2 的影响,表明 G(12/13)下游的 SFKs(而不是 G(q)/G(i))作为血小板激活的负调节剂发挥作用。此外,PP2 增强了 YFLLRNP 和 AYPGKF 诱导的 PKC 激活,表明 G(12/13)下游的 SFKs 通过负调节 PKC 激活以及钙反应来调节血小板反应。在存在 G(q)-选择性抑制剂 YM254890 或在 G(q)缺陷型血小板中,SFK 抑制剂未能增强血小板反应,表明 SFKs 通过调节 G(q)途径负调节血小板反应。重要的是,与野生型同窝仔相比,在 Fyn 缺陷型而非 Lyn 缺陷型小鼠中,AYPGKF 诱导的血小板聚集和 PKC 激活增强。我们得出结论,SFKs,特别是 Fyn,通过抑制 G(q)途径的细胞内钙动员和 PKC 激活,在 G(12/13)下游的负调节血小板反应。